About Us
The 7th Ace Clinical Trials Summit USA 2026 (7th ACTS) brings together leading experts, innovators, and stakeholders to explore cutting-edge advancements shaping the future of clinical research. With a strong focus on AI integration, patient-centric approaches, decentralized trials, real-world evidence, and sustainable practices, the summit will deliver two impactful days of presentations, panel discussions, and business meetings. Key themes include digital transformation, generative AI in recruitment, ethical challenges in tech-enabled trials, and the evolving role of data and technology in global operations. Delegates will engage in in-depth conversations around rare diseases, patient engagement, and blockchain applications, driving forward innovation in clinical development. The summit provides unparalleled networking opportunities and actionable insights for CROs, sponsors, biotech firms, and regulatory professionals looking to accelerate trial efficiency, enhance patient outcomes, and transform clinical operations for the future. Join us to shape what’s next in clinical trials.
Why Attend





Solutions at ACTS
The 7th Ace Clinical Trials Summit USA 2026 (7th ACTS) brings together leading experts, innovators, and stakeholders to explore cutting-edge advancements shaping the future of clinical research.
🔷BiostatisticsÂ
🔷Central Laboratory Services
🔷Clinical Data Management
🔷Clinical Monitoring
🔷Clinical Operations
🔷E-Marketing & E-Commerce
🔷Clinical Operations
🔷Clinical Operations Management Solutions
🔷Clinical Research
🔷Clinical Trials Management
🔷Comparator Sourcing & Drug Procurement
🔷Contract Research Organizations (CROs)
🔷Development Operations
🔷Pharmacovigilance & Drug Safety
🔷Quality Assurance
🔷Patient Recruitment & Retention
🔷Regulatory Affairs
🔷Statistical Programming
🔷Device Testing
🔷eClinical Technologies
🔷Electronic Data Capture (EDC)
🔷Global Clinical R&D
🔷Global Project & Site Management
🔷Health Economics & Outcomes Research
🔷Imaging Tools
Who Will Attend
The 7th Ace Clinical Trials Summit USA 2026 (7th ACTS) brings together leading experts, innovators, and stakeholders to explore cutting-edge advancements shaping the future of clinical research
🔷Directors of Medical Affairs
🔷Heads of Clinical Operations
🔷Clinical Country Leads
🔷Clinical Site Managers
🔷Directors of Clinical Statistics
🔷Clinical Project Managers
🔷Clinical Trials Managers
🔷Heads of Clinical Trials Outsourcing
🔷Directors of Clinical Development
🔷Budgeting & Outsourcing Directors
🔷Biostatisticians
🔷Clinical Data & Site ManagementÂ
🔷Risk-Based Monitoring Directors
🔷Clinical Trials R&D Executives
Thought Leaders
Pedro Coelho
CEO | Biorce
Yong Chen
Sr. Director | Pfizer
Uday Harle
Chief Scientific Officer / Advisor | Premedium Pharmaceuticals
Lina Valero
Pharmacovigilance Head LATAM | Sanofi | Opella
Oliver Overheu
Medical Oncologist | MBA Candidate | Duke University
Dr. Rosita Ezemma
Associate Director, Global Clinical Trial Lead | Takeda Pharmaceuticals
Arjun Channi
Director, Global Regulatory Affairs | Sanofi
Singaiah kukkapalli
 Director | Yoshe Clinical Operations LTD
Lyanna Ly
AVP & System Executive Director, Cancer Center | RUSH MD Anderson
Ekta Grewal
Founder | Sikhs In Clinical Research
Kaye Doiron
Founder | Research Works INC
Dr Jennifer Onwumeh-Okwundu
Director Clinical Scientist vaccines | Pfizer
Rohan Nanda
Executive Medical Director & Early Phase Drug Safety Physician | Eli Lilly and Company
Ifeyinwa (Ify) Osunkwo
Global Advocacy Lead, Hemoglobinopathies | Novo Nordisk Rare Disease
Anastasia Gutierrez
VP Clinical Operations | Immuneering Corporation
Attendee Breakdown
Attendee Demographics
2026 Conference Themes
06 May
Driving Innovation in Clinical Operations
Smarter site selection
AI-Enhanced Patient-Centric Clinical Trial Design
Standardizing Patient Engagement in Drug Development
Next-Gen Clinical Trials
Scientific Superintelligence And Future Of Clinical Trials
Clinical Data Management
07 May
